Cotinga Pharmaceuticals (Cotinga Pharmaceuticals) Tax Rate % : 0.00% (As of Jan. 2020)

View and export this data going back to 2007. Start your Free Trial

What is Cotinga Pharmaceuticals Tax Rate %?

Tax Rate % is calculated as Tax Expense divided by its Pre-Tax Income. Cotinga Pharmaceuticals's Tax Expense for the three months ended in Jan. 2020 was $0.00 Mil. Cotinga Pharmaceuticals's Pre-Tax Income for the three months ended in Jan. 2020 was $-0.41 Mil. Therefore, Cotinga Pharmaceuticals's Tax Rate % for the quarter that ended in Jan. 2020 was 0.00%.

Cotinga Pharmaceuticals Tax Rate % Historical Data

The historical data trend for Cotinga Pharmaceuticals's Tax Rate % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cotinga Pharmaceuticals Tax Rate % Chart

Cotinga Pharmaceuticals Annual Data

Trend

Apr10

Apr11

Apr12

Apr13

Apr14

Apr15

Apr16

Apr17

Apr18

Apr19

Tax Rate %

Get a 7-Day Free Trial

Cotinga Pharmaceuticals Quarterly Data
	Apr15	Jul15	Oct15	Jan16	Apr16	Jul16	Oct16	Jan17	Apr17	Jul17	Oct17	Jan18	Apr18	Jul18	Oct18	Jan19	Apr19	Jul19	Oct19	Jan20
Tax Rate %	Get a 7-Day Free Trial															-	-	-	-	-

Cotinga Pharmaceuticals Tax Rate % Calculation

Tax Rate % is the ratio of tax expense divided by pretax income, usually presented in percent.

Cotinga Pharmaceuticals's Tax Rate % for the fiscal year that ended in Apr. 2019 is calculated as

Tax Rate %	=	Tax Expense (A: Apr. 2019 )	/	Pre-Tax Income (A: Apr. 2019 )
	=	0	/	-2.016
	=	0.00 %

Cotinga Pharmaceuticals's Tax Rate % for the quarter that ended in Jan. 2020 is calculated as

Tax Rate %	=	Tax Expense (Q: Jan. 2020 )	/	Pre-Tax Income (Q: Jan. 2020 )
	=	0	/	-0.408
	=	0.00 %

Cotinga Pharmaceuticals Tax Rate % Related Terms

Thank you for viewing the detailed overview of Cotinga Pharmaceuticals's Tax Rate % provided by GuruFocus.com. Please click on the following links to see related term pages.

Cotinga Pharmaceuticals (Cotinga Pharmaceuticals) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cotinga Pharmaceuticals Inc (OTCPK:COTQF) » Definitions » Tax Rate %

Comparable Companies

Traded in Other Exchanges

N/A

Address

82 Richmond Street East, The Canadian Venture Building, Toronto, ON, CAN, M5C1P1

Website

http://www.cotingapharma.com

Cotinga Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company's lead clinical candidate, COTI-2, is an oral small molecule targeting p53, a tumor suppressor gene that is mutated in over 50% of all cancers, and the company's second clinical candidate, COTI-219, is a novel oral small molecule compound targeting the mutant forms of KRAS with such mutations occurring in up to 30% of all cancers.

Cotinga Pharmaceuticals (Cotinga Pharmaceuticals) Headlines

From GuruFocus

Cotinga Pharmaceuticals Reports Fiscal 2018 Third Quarter Financial and Operating Results

By GlobeNewswire GlobeNewswire • 04-03-2018

Cotinga Pharmacueticals Announces Closing of Unit Offering

By GlobeNewswire GlobeNewswire • 05-22-2019